The expression of PTGS2, a marker of ferroptosis [31], was enhanced upon RSL3 treatment and further enhanced after ICG001 cotreatment, according to isolated tumor-related IF staining results (Figure 3e). This evidence concerns the gene PTGS2 and neoplasm.